Alzamend Neuro, Inc.

ALZNNASDAQ Capital Market·USD·Closed

ALZNNASDAQ·USD·Closed

$1.15

−1.29%

$1.15

−$0.01 (1.29%)

52W Range

11thpctl

Volume

0.17×avg

Mkt Cap

3.60MUSD

P/E

-0.7TTM

Div Yield

–ann

Healthcare · Biotechnology

52W Range

11thpctl

Volume

0.17×avg

Market Cap

3.60MUSD

P/E Ratio

-0.7TTM

Div Yield

-ann

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-322.0%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage-1008.2×

Current ratio1.99×

Continue with finqOS

Unlock the full picture

SEC filings, earnings transcripts, insider trades, institutional ownership, 175+ screening metrics, and an infinite research canvas.

14-day free trial · No credit card required